BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3350159)

  • 1. The efficiency of human reproduction after in vitro fertilization and embryo transfer.
    Liu HC; Jones HW; Rosenwaks Z
    Fertil Steril; 1988 Apr; 49(4):649-53. PubMed ID: 3350159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of low-dose human chorionic gonadotropin on corpus luteum function after embryo transfer.
    Mahadevan MM; Leader A; Taylor PJ
    J In Vitro Fert Embryo Transf; 1985 Dec; 2(4):190-4. PubMed ID: 4093702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between serum progesterone level at the day with human chorionic gonadotrophin administration and the outcome of pregnancy in in-vitro fertilization].
    Xi QP; Mao YD; Gao Y; Ding W; Wang W; Ma X; Diao FY; Huang J; Qian XQ; Cai LB; Feng T; Yan ZJ; Liu JY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Feb; 45(2):118-23. PubMed ID: 20420782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early pregnancy wastage following late implantation of embryos after in-vitro fertilization and embryo transfer.
    Hamori M; Stuckensen JA; Rumpf D; Kniewald T; Kniewald A; Marquez M
    Hum Reprod; 1989 Aug; 4(6):714-7. PubMed ID: 2476462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting pregnancy outcome after in vitro fertilization and embryo transfer using estradiol, progesterone, and human chorionic gonadotropin beta-subunit.
    Yamashita T; Okamoto S; Thomas A; MacLachlan V; Healy DL
    Fertil Steril; 1989 Feb; 51(2):304-9. PubMed ID: 2463940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early hormonal markers of pregnancy outcome after in vitro fertilization and embryo transfer.
    Carmona F; Balasch J; Creus M; Fábregues F; Casamitjana R; Cívico S; Vidal E; Calafell JM; Moreno V; Vanrell JA
    J Assist Reprod Genet; 2003 Dec; 20(12):521-6. PubMed ID: 15035553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
    Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
    Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome.
    Sharara FI; McClamrock HD
    Hum Reprod; 1999 Nov; 14(11):2777-82. PubMed ID: 10548621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteal phase hormonal profile in prediction of pregnancy outcome after assisted reproduction.
    Vicdan K; Zeki Isik A
    Eur J Obstet Gynecol Reprod Biol; 2001 May; 96(1):98-101. PubMed ID: 11311769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles.
    Farhi J; Weissman A; Steinfeld Z; Shorer M; Nahum H; Levran D
    Fertil Steril; 2000 Apr; 73(4):761-6. PubMed ID: 10731538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.
    Herman A; Raziel A; Strassburger D; Soffer Y; Bukovsky I; Ron-El R
    Hum Reprod; 1996 Jul; 11(7):1552-7. PubMed ID: 8671503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced oestradiol secretion briefly after embryo transfer in conception cycles from IVF.
    Greb RR; Lettmann N; Sonntag B; Schüring AN; von Otte S; Kiesel L
    Reprod Biomed Online; 2004 Sep; 9(3):271-8. PubMed ID: 15353074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone.
    Buvat J; Marcolin G; Guittard C; Herbaut JC; Louvet AL; Dehaene JL
    Fertil Steril; 1990 Mar; 53(3):490-4. PubMed ID: 2407565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer.
    Fanchin R; de Ziegler D; Taieb J; Hazout A; Frydman R
    Fertil Steril; 1993 May; 59(5):1090-4. PubMed ID: 8486179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles.
    Fujimoto A; Osuga Y; Fujiwara T; Yano T; Tsutsumi O; Momoeda M; Kugu K; Koga K; Morita Y; Wada O; Taketani Y
    J Assist Reprod Genet; 2002 Dec; 19(12):550-4. PubMed ID: 12503886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of treatment with human chorionic gonadotropin 7 days after artificial insemination or at the time of embryo transfer on reproductive outcomes in nulliparous Holstein heifers.
    Niles AM; Fricke HP; Carvalho PD; Wiltbank MC; Hernandez LL; Fricke PM
    J Dairy Sci; 2019 Mar; 102(3):2593-2606. PubMed ID: 30692012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens.
    Wong YF; Loong EP; Mao KR; Tam PP; Panesar NS; Neale E; Chang AM
    Reprod Fertil Dev; 1990; 2(4):351-8. PubMed ID: 2217893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-human chorionic gonadotropin as a monitor of pregnancy outcome in in vitro fertilization-embryo transfer patients.
    Liu HC; Kreiner D; Muasher SJ; Jones G; Jones H; Rosenwaks Z
    Fertil Steril; 1988 Jul; 50(1):89-94. PubMed ID: 3384122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could aspiration of the Graafian follicle cause luteal phase deficiency?
    Feichtinger W; Kemeter P; Szalay S; Beck A; Janisch H
    Fertil Steril; 1982 Feb; 37(2):205-8. PubMed ID: 6174376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.